Evidence map›Paper›PMID 36100039›Full record

ArticleThe Journal of biological chemistry2022

Glucocorticoid receptor dysregulation underlies 5-HT

Justin M Saunders, Carolina Muguruza, Salvador Sierra, José L Moreno, Luis F Callado, J Javier Meana, Patrick M Beardsley, Javier González-Maeso

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Stereoselective, sex-dependent 5-HTNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Justin M SaundersDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Carolina MuguruzaDepartment of Pharmacology, University of the Basque Country UPV/EHU, CIBERSAM, Biocruces Bizkaia Health Research Institute, Leioa, Bizkaia, Spain.
Salvador SierraDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
José L MorenoDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Luis F CalladoDepartment of Pharmacology, University of the Basque Country UPV/EHU, CIBERSAM, Biocruces Bizkaia Health Research Institute, Leioa, Bizkaia, Spain.
J Javier MeanaDepartment of Pharmacology, University of the Basque Country UPV/EHU, CIBERSAM, Biocruces Bizkaia Health Research Institute, Leioa, Bizkaia, Spain.
Patrick M BeardsleyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA; Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
Javier González-MaesoDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA. Electronic address: javier.maeso@vcuhealth.org.
Virginia Commonwealth University · USUniversity of the Basque Country · ES

Funding

Structure and function of the 5HT2A/mGluR2 complex in schizophreniaR01MH084894 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI Javier Gonzalez-Maeso · 2009 to 2026
$6.8M
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatmentR01MH111940 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI GONZÁLEZ-MAESO, JAVIER · 2017 to 2021
$1.5M
Gut dysbiosis and 5-HT2A dysregulation in a preclinical schizophrenia modelF30MH116550 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI SAUNDERS, JUSTIN M · 2018 to 2021
$151k
NIMH NIH HHS F30 MH116550NIMH NIH HHS R01 MH084894NIMH NIH HHS R01 MH111940
6 · The paper itself

Abstract

Prenatal environmental insults increase the risk of neurodevelopmental psychiatric conditions in the offspring. Structural modifications of dendritic spines are central to brain development and plasticity. Using maternal immune activation (MIA) as a rodent model of prenatal environmental insult, previous results have reported dendritic structural deficits in the frontal cortex. However, very little is known about the molecular mechanism underlying MIA-induced synaptic structural alterations in the offspring. Using prenatal (E12.5) injection with polyinosinic-polycytidylic acid potassium salt as a mouse MIA model, we show here that upregulation of the serotonin 5-HT

Indexed as

Neurodevelopmental DisordersSchizophreniaAnimalsDisease Models, AnimalFemaleHumansMicePregnancyReceptor, Serotonin, 5-HT2AReceptors, GlucocorticoidSerotoninReceptor, Serotonin, 5-HT2AReceptors, GlucocorticoidSerotonindendritic spinesglucocorticoid receptorG protein–coupled receptormaternal immune activationneurodevelopmental psychiatric conditionsschizophreniaserotonin 5-HT(2A) receptor

Identifiers

PMID36100039
PMCPMC9589215
OpenAlexW4295242255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.